Sort
78,016 grants matching “breast cancer”
A RESOURCE FOR BIOMEDICAL MASS SPECTROMETRY
$991,094Washington University · P41 · FY2001 · RR
PROSPR Statistical Coordinating Center (PSCC)
$991,008William E Barlow · Fred Hutchinson Cancer Research Center · U01 · FY2013 · CA
Koning Cone Beam Breast CT
$990,922David L Conover · Koning Corporation · R44 · FY2011 · CA
Investigate the DNA damage response pathway of Fanconi anemia and BRCA proteins
$990,856Weidong Wang · National Institute On Aging · ZIA · FY2018 · AG
Characterization of a Complex Involved In Rothmund-Thomson Syndrome
$990,856Weidong Wang · National Institute On Aging · ZIA · FY2018 · AG
SCREENING MAMMOGRAPHY AND LATINAS: A MULTILEVEL INTERVENTION
$990,515Gloria D Coronado · Fred Hutchinson Cancer Research Center · P50 · FY2010 · CA
EXPLOITING THE REMODELING OF CA2+ SIGNALING IN BREAST CANCER CELL MICROENVIRONMENTS TO CONTROL METASTASIS AND TO SPECIFICALLY TARGET BRAIN METASTASES
$990,460The University Of Queensland · · FY2017 · Department of the Army
SBIR PHASE II: SITE-SPECIFIC ANTIBODIES FOR GLCNACYLATED PROTEINS IN CANCER
$989,975Hyesook Kim · Detroit R & D, Inc. · N44 · FY2013 · CA
Mass Spectrometry Quantitation
$989,919Leesa Deterding · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES
Measuring Cancer Biomarker Candidates by Targeted MS and Ab Enrichment
$989,858Steven A. Carr · Broad Institute, Inc. · U24 · FY2008 · CA
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
$989,275Scarlett L Gomez · University Of California, San Francisco · R01 · FY2024 · CA
Evaluation of Commercial Mammography-Based Artificial Intelligence Algorithms for Breast Cancer Risk Prediction in U.S. Screening Populations
$989,122Kathryn Paige Lowry · University Of Washington · R37 · FY2024 · CA
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures
$989,046Shiuan Chen · Beckman Research Institute/City Of Hope · U01 · FY2016 · ES
Detecting breast cancer with a simple blood test using an accessible and low-cost novel real-time platform
$989,025Eagappanath Thiruppathi · Inanovate, Inc. · R44 · FY2019 · CA
Discovery, Biology and Risk of Inherited Variants in Glioma
$989,011Melissa L Bondy · Stanford University · R01 · FY2021 · CA
Vitamin D, Related Genes and Breast Cancer Risk
$988,767Anne Zeleniuch-Jacquotte · New York University School Of Medicine · R01 · FY2011 · CA
Phase I Clinical Testing of a First-in-Class Therapy against Metastatic Cancer
$988,765Zdravka O. Medarova · Transcode Therapeutics, Inc. · R44 · FY2025 · CA
Molecular, Cellular, and Tissue Characterization Unit
$988,750William E Gillanders · Washington University · U2C · FY2021 · CA
Optimizing Implementation in Cancer Control: OPTICC
$988,432Bryan J. Weiner · University Of Washington · P50 · FY2019 · CA
TARGETING GPR110 IN HER2-OVEREXPRESSING BREAST CANCER
$988,427University Of Houston System · · FY2014 · Department of the Army
Risk prediction methods
$988,223Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
Roles of tumor suppressors (TSs) in metastatic progression
$988,119Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Myeloid TGFbeta signaling in breast cancer metastasis
$988,119Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
PNNL Proteome Characterization Center
$987,941Tao Liu · Battelle Pacific Northwest Laboratories · U24 · FY2020 · CA
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
$987,911Dashtimoghadam Erfan · Symphony Biosciences, Inc. · R44 · FY2025 · CA